Opill (norgestrel) is a small molecule pharmaceutical. Norgestrel was first approved as Opill on 1982-01-01. The pharmaceutical is active against progesterone receptor.
Trade Name |
Opill |
Common Name |
Norgestrel |
Indication |
|
Drug Class |
Estrogens; progestins |